Caring Brands (NASDAQ:CABR) Posts Earnings Results

Caring Brands (NASDAQ:CABR) released its earnings results on Tuesday. The company reported ($0.29) earnings per share (EPS) for the quarter, Zacks reports.

Caring Brands Trading Down 1.3%

NASDAQ CABR traded down $0.02 on Wednesday, hitting $1.13. 3,396 shares of the company’s stock traded hands, compared to its average volume of 150,713. The stock’s 50-day moving average price is $0.90. Caring Brands has a 1-year low of $0.71 and a 1-year high of $5.35.

Institutional Investors Weigh In On Caring Brands

An institutional investor recently bought a new position in Caring Brands stock. Jane Street Group LLC acquired a new position in Caring Brands, Inc. (NASDAQ:CABR) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned approximately 0.25% of Caring Brands at the end of the most recent quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings initiated coverage on Caring Brands in a research note on Monday, January 26th. They set a “sell (e)” rating on the stock. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

Caring Brands Company Profile

We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.